Mphasis Intrinsic Value
MPHASIS • Information Technology
Current Stock Price
₹2209.90
Primary Intrinsic Value
₹1183.20
Market Cap
₹419.9K Cr
-54.5%
Downside
Median Value
₹1004.81
Value Range
₹507 - ₹1382
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%
MPHASIS Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹1183.20 | ₹946.56 - ₹1419.84 | -46.5% | EPS: ₹98.60, Sector P/E: 12x |
| Book Value Method | asset | ₹506.74 | ₹456.07 - ₹557.41 | -77.1% | Book Value/Share: ₹506.74, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹669.81 | ₹602.83 - ₹736.79 | -69.7% | Revenue/Share: ₹837.26, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹1005.47 | ₹904.92 - ₹1106.02 | -54.5% | EBITDA: ₹3184.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹1004.81 | ₹803.85 - ₹1205.77 | -54.5% | CF Growth: 7.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹662.97 | ₹596.67 - ₹729.27 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹812.46 | ₹731.21 - ₹893.71 | -63.2% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹1382.32 | ₹1244.09 - ₹1520.55 | -37.4% | ROE: 19.5%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹1013.47 | ₹912.12 - ₹1114.82 | -54.1% | EPS: ₹98.60, BVPS: ₹506.74 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
MPHASIS Intrinsic Value Analysis
What is the intrinsic value of MPHASIS?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Mphasis (MPHASIS) is ₹1004.81 (median value). With the current market price of ₹2209.90, this represents a -54.5% variance from our estimated fair value.
The valuation range spans from ₹506.74 to ₹1382.32, indicating ₹506.74 - ₹1382.32.
Is MPHASIS undervalued or overvalued?
Based on our multi-method analysis, Mphasis (MPHASIS) appears to be trading above calculated value by approximately 54.5%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 8.42 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 19.5% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 18.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.07x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Mphasis
Additional stock information and data for MPHASIS
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹1,905 Cr | ₹1,905 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹2,180 Cr | ₹932 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹1,462 Cr | ₹1,462 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹1,716 Cr | ₹1,581 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹1,455 Cr | ₹1,050 Cr | Positive Free Cash Flow | 8/10 |